<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
-------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
AUGUST 8, 2000
CUBIST PHARMACEUTICALS, INC
---------------------------
(Exact Name of Registrant as Specified in Charter)
DELAWARE 0-21379 22-3192085
---------------------------- -------------- ---------------------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
24 Emily Street, Cambridge, Massachusetts 02139
---------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (617) 576-1999
--------------
<PAGE>
ITEM 5. OTHER EVENTS.
On August 8, 2000, the Registrant issued a joint press release
announcing that it signed a definitive agreement to acquire TerraGen Discovery,
Inc., a privately held company with operations in Vancouver, Canada and Slough,
England. The press release has been filed as an exhibit to this Report on Form
8-K, attached hereto as Exhibit 99.1.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(C) EXHIBITS.
99.1 Press Release dated August 8, 2000
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CUBIST PHARMACEUTICALS, INC.
By: /s/ Alan D. Watson
-------------------------------------
Alan D. Watson
Senior Vice President
Dated: August 10, 2000
